Literature DB >> 11710682

Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review.

F Koster1, K Foucar, B Hjelle, A Scott, Y Y Chong, R Larson, M McCabe.   

Abstract

Hantavirus cardiopulmonary syndrome (HCPS) is a rare but frequently lethal acute zoonotic viral infection in rural North America. The rapidity of progression from febrile prodrome to cardiogenic shock and noncardiogenic pulmonary edema requiring intensive care creates high diagnostic urgency and a need for a rapid screening tool. In this retrospective cohort study, 2 pathologists scored blinded peripheral blood smears from 52 patients with HCPS and 128 seronegative patients referred for diagnosis of suspected hantavirus infection. During the prodromal phase, thrombocytopenia was the only consistent abnormality and could be used to indicate hantavirus serologic testing. After the onset of pulmonary edema detected radiographically, the presence of 4 of 5 findings (thrombocytopenia, myelocytosis, hemoconcentration, lack of significant toxic granulation in neutrophils, and more than 10% of lymphocytes with immunoblastic morphologic features) has a sensitivity for HCPS of 96% and a specificity of 99% and missed no patients with HCPS who required intensive care. While each abnormality is commonly seen, the combination of at least 4 of these CBC count data and peripheral blood smear findings can guide early treatment and patient transport decisions until rapid, specific, serologic testing becomes widely available.

Entities:  

Mesh:

Year:  2001        PMID: 11710682     DOI: 10.1309/CNWF-DC72-QYMR-M8DA

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  33 in total

1.  Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches.

Authors:  Erich R Mackow; Elena E Gorbunova; Nadine A Dalrymple; Irina N Gavrilovskaya
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

2.  Central nervous system complications following Hanta virus cardiopulmonary syndrome.

Authors:  Branko N Huisa; John E Chapin; John C Adair
Journal:  J Neurovirol       Date:  2009-04       Impact factor: 2.643

3.  Hantavirus fever without pulmonary syndrome in Panama.

Authors:  Blas Armien; Juan M Pascale; Carlos Muñoz; Jamileth Mariñas; Heydy Núñez; Milagro Herrera; José Trujillo; Deyanira Sánchez; Yaxelis Mendoza; Brian Hjelle; Frederick Koster
Journal:  Am J Trop Med Hyg       Date:  2013-07-08       Impact factor: 2.345

4.  Establishment of SYBR green-based qPCR assay for rapid evaluation and quantification for anti-Hantaan virus compounds in vitro and in suckling mice.

Authors:  Fei Wei; Jin-lin Li; Jia-xin Ling; Liang-Jun Chen; Ning Li; Yuan-Yuan Liu; Fan Luo; Hai-Rong Xiong; Wei Hou; Zhan-Qiu Yang
Journal:  Virus Genes       Date:  2012-10-10       Impact factor: 2.332

5.  VEGFR2 and Src kinase inhibitors suppress Andes virus-induced endothelial cell permeability.

Authors:  Elena E Gorbunova; Irina N Gavrilovskaya; Timothy Pepini; Erich R Mackow
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

6.  Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells.

Authors:  Irina N Gavrilovskaya; Elena E Gorbunova; Erich R Mackow
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

7.  Massive plasmablast response elicited in the acute phase of hantavirus pulmonary syndrome.

Authors:  Marina García; Ayelén Iglesias; Verónica I Landoni; Carla Bellomo; Agostina Bruno; María Teresa Córdoba; Luciana Balboa; Gabriela C Fernández; María Del Carmen Sasiain; Valeria P Martínez; Pablo Schierloh
Journal:  Immunology       Date:  2017-02-09       Impact factor: 7.397

8.  Slit2-Robo4 receptor responses inhibit ANDV directed permeability of human lung microvascular endothelial cells.

Authors:  Elena E Gorbunova; Irina N Gavrilovskaya; Erich R Mackow
Journal:  Antiviral Res       Date:  2013-05-20       Impact factor: 5.970

9.  The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster.

Authors:  Joseph Prescott; David Safronetz; Elaine Haddock; Shelly Robertson; Dana Scott; Heinz Feldmann
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

10.  Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability.

Authors:  Irina N Gavrilovskaya; Elena E Gorbunova; Natalie A Mackow; Erich R Mackow
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.